Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
EA
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.15% |
| 2 | Technology | 16.1% |
| 3 | Financials | 11.82% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRBK
2526
DELISTED
Republic First Bancorp Inc
FRBK
| $1.15M | ﹤0.01% |
124,300
-55,112
| -31% | -$491K |
|
2527
Noodles & Co
NDLS
$98M
| $1.15M | ﹤0.01% |
32,588
-16,312
| -33% | -$536K |
|
2528
Flanigan's Enterprises
BDL
$80.7M
| $1.15M | ﹤0.01% |
47,200
| – | – |
|
2529
ACNB Corp
ACNB
$656M
| $1.14M | ﹤0.01% |
41,141
+13,146
| +47% | +$366K |
|
2530
Emerson Radio
MSN
$7.99M
| $1.14M | ﹤0.01% |
850,600
+6,500
| +0.8% | +$8.41K |
|
2531
Teekay Tankers
TNK
$2.81B
| $1.14M | ﹤0.01% |
87,951
+47,300
| +116% | +$607K |
|
2532
Norwood Financial Corp
NWFL
$376M
| $1.13M | ﹤0.01% |
37,150
+19,450
| +110% | +$560K |
|
2533
Clearwater Paper
CLW
$356M
| $1.13M | ﹤0.01% |
23,000
-29,325
| -56% | -$1.37M |
|
|
LEJU
2534
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $1.13M | ﹤0.01% |
67,040
+24,770
| +59% | +$407K |
|
2535
Apyx Medical
APYX
$126M
| $1.13M | ﹤0.01% |
333,300
+9,600
| +3% | +$24.8K |
|
|
ALR
2536
DELISTED
AlerisLife Inc
ALR
| $1.13M | ﹤0.01% |
72,714
+10,900
| +18% | +$175K |
|
|
NMRX
2537
DELISTED
Numerex Corp
NMRX
| $1.13M | ﹤0.01% |
296,600
+16,800
| +6% | +$69.7K |
|
|
PFIE
2538
DELISTED
Profire Energy, Inc
PFIE
| $1.12M | ﹤0.01% |
563,335
+186,135
| +49% | +$277K |
|
|
TRT
2539
Trio-Tech International
TRT
$118M
| $1.12M | ﹤0.01% |
426,040
+55,640
| +15% | +$128K |
|
2540
Weyco Group
WEYS
$446M
| $1.11M | ﹤0.01% |
39,100
+8,700
| +29% | +$242K |
|
2541
Lineage Cell Therapeutics
LCTX
$268M
| $1.11M | ﹤0.01% |
446,113
+302,544
| +211% | +$750K |
|
|
FWP
2542
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $1.1M | ﹤0.01% |
+25,986
| New | +$3.61M |
|
2543
SiteOne Landscape Supply
SITE
$4.27B
| $1.1M | ﹤0.01% |
+18,900
| New | +$989K |
|
|
CRHM
2544
DELISTED
CRH Medical Corporation
CRHM
| $1.09M | ﹤0.01% |
419,100
-4,120
| -1% | -$12.7K |
|
|
VG
2545
DELISTED
Vonage Holdings Corporation
VG
| $1.09M | ﹤0.01% |
133,826
-341,500
| -72% | -$2.57M |
|
|
NVTR
2546
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $1.09M | ﹤0.01% |
81,900
-11,700
| -13% | -$139K |
|
2547
Coca-Cola Consolidated
COKE
$12.6B
| $1.08M | ﹤0.01% |
50,270
-228,000
| -82% | -$5.03M |
|
2548
iShares MSCI South Korea ETF
EWY
$27.6B
| $1.08M | ﹤0.01% |
+15,700
| New | +$1.08M |
|
|
BBQ
2549
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $1.08M | ﹤0.01% |
260,400
-13,000
| -5% | -$51.3K |
|
2550
Omega Flex
OFLX
$304M
| $1.07M | ﹤0.01% |
14,900
-300
| -2% | -$18.8K |
|
Similar funds
Jim Simons's Q3 2017 Portfolio in Review
As of Q3 2017, Jim Simons held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Jim Simons deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Jim Simons's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Jim Simons added most to Medtronic in Q3 2017, an estimated $495M increase.
- Jim Simons's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Jim Simons fully exited Amazon in Q3 2017, selling an estimated $290M.
- Jim Simons's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Jim Simons opened 418 new positions and closed 418 in Q3 2017.
- Jim Simons's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.